These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27063768)

  • 21. Effects of intraoperatively applied glucocorticoid hydrogels on residual hearing and foreign body reaction in a guinea pig model of cochlear implantation.
    Honeder C; Landegger LD; Engleder E; Gabor F; Plasenzotti R; Plenk H; Kaider A; Hirtler L; Gstoettner W; Arnoldner C
    Acta Otolaryngol; 2015 Apr; 135(4):313-9. PubMed ID: 25720453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of PLGA-PEG-PLGA copolymer hydrogel for sustained drug delivery in the ear.
    Feng L; Ward JA; Li SK; Tolia G; Hao J; Choo DI
    Curr Drug Deliv; 2014; 11(2):279-86. PubMed ID: 24438444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S; Janoria KG; Mitra AK
    J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficiency of a dexamethasone nanosuspension as an intratympanic injection for acute hearing loss.
    Jung SY; Kim S; Kang Z; Kwon S; Lee J; Park JW; Kim KS; Kim DK
    Drug Deliv; 2022 Dec; 29(1):149-160. PubMed ID: 34967280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous topical drug delivery using osmotic pump in animal cochlear implant model: Continuous steroid delivery is effective for hearing preservation.
    Lee MY; Lee JH; Lee HS; Choi JJ; Jang J; Choi H; Oh SH; Jang JH
    Acta Otolaryngol; 2015 Aug; 135(8):791-8. PubMed ID: 25813859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity.
    Chen Y; Gu J; Liu J; Tong L; Shi F; Wang X; Wang X; Yu D; Wu H
    Int J Nanomedicine; 2019; 14():4211-4227. PubMed ID: 31239676
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of a dexamethasone-releasing implant on cochleae: A functional, morphological and pharmacokinetic study.
    Liu Y; Jolly C; Braun S; Janssen T; Scherer E; Steinhoff J; Ebenhoch H; Lohner A; Stark T; Kiefer J
    Hear Res; 2015 Sep; 327():89-101. PubMed ID: 25987502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intratympanic application of poloxamer 407 hydrogels results in sustained N-acetylcysteine delivery to the inner ear.
    Gausterer JC; Saidov N; Ahmadi N; Zhu C; Wirth M; Reznicek G; Arnoldner C; Gabor F; Honeder C
    Eur J Pharm Biopharm; 2020 May; 150():143-155. PubMed ID: 32173603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I study of combination therapy with intravenous cidofovir and oral ganciclovir for cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA; Wilson S; Stanley H; Holtzer C; Cherrington J; Safrin S
    Clin Infect Dis; 1999 Mar; 28(3):528-33. PubMed ID: 10194072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dexamethasone prevents hearing loss by restoring glucocorticoid receptor expression in the guinea pig cochlea.
    Heinrich UR; Strieth S; Schmidtmann I; Stauber R; Helling K
    Laryngoscope; 2016 Jan; 126(1):E29-34. PubMed ID: 25946598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexamethasone loaded nanoparticles exert protective effects against Cisplatin-induced hearing loss by systemic administration.
    Sun C; Wang X; Chen D; Lin X; Yu D; Wu H
    Neurosci Lett; 2016 Apr; 619():142-8. PubMed ID: 26971701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Sustained-Exposure Dexamethasone Formulation OTO-104 Offers Effective Protection against Noise-Induced Hearing Loss.
    Harrop-Jones A; Wang X; Fernandez R; Dellamary L; Ryan AF; LeBel C; Piu F
    Audiol Neurootol; 2016; 21(1):12-21. PubMed ID: 26655654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue.
    Bidanset DJ; Rybak RJ; Hartline CB; Kern ER
    Antiviral Res; 2004 Jul; 63(1):61-4. PubMed ID: 15196821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapy.
    Bowen EF; Cherrington JM; Lamy PD; Griffiths PD; Johnson MA; Emery VC
    J Med Virol; 1999 Aug; 58(4):402-7. PubMed ID: 10421408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation.
    Cesaro S; Pillon M; Tridello G; Aljurf M; Martino R; Schroyens W; Nozzoli C; Barba P; Faraci M; Fagioli F; Cappelli B; Cordonnier C; Al-Mohareb F; Floisand Y; Greil J; Panizzolo IS; Santarone S
    Bone Marrow Transplant; 2013 Jun; 48(6):809-13. PubMed ID: 23222380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo evaluation of a hydrogel reservoir as a continuous drug delivery system for inner ear treatment.
    Hütten M; Dhanasingh A; Hessler R; Stöver T; Esser KH; Möller M; Lenarz T; Jolly C; Groll J; Scheper V
    PLoS One; 2014; 9(8):e104564. PubMed ID: 25105670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs.
    Daldal A; Odabasi O; Serbetcioglu B
    Otolaryngol Head Neck Surg; 2007 Nov; 137(5):747-52. PubMed ID: 17967639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of low-dose intratympanic dexamethasone for sudden hearing loss.
    Günel C; Başal Y; Toka A; Eryılmaz A; Kurt Ömürlü I
    Auris Nasus Larynx; 2015 Aug; 42(4):284-7. PubMed ID: 25725564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of intratympanic formulations for inner ear delivery: methodology and sustained release formulation testing.
    Liu H; Feng L; Tolia G; Liddell MR; Hao J; Li SK
    Drug Dev Ind Pharm; 2014 Jul; 40(7):896-903. PubMed ID: 23631539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel controlled local drug delivery system for inner ear disease.
    Paulson DP; Abuzeid W; Jiang H; Oe T; O'Malley BW; Li D
    Laryngoscope; 2008 Apr; 118(4):706-11. PubMed ID: 18182968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.